Abstract Number: 986 • 2013 ACR/ARHP Annual Meeting
Participant and Educator Feedback Informs Delivery Of An Interprofessional Inflammatory Arthritis Education Program Using Telemedicine In Rural Communities
Background/Purpose: Telemedicine-based approaches to healthcare service delivery are known to improve access to care, as well as the efficiency, quality and timeliness of healthcare service…Abstract Number: 987 • 2013 ACR/ARHP Annual Meeting
Improving Access To Subspecialty Care For Underserved Communities: A Rheumatology Patient Navigator Pilot Intervention
Background/Purpose: Early and sustained access to rheumatology care can improve access to disease-modifying medications and reduce disparities in outcomes. In one state, more than one-half…Abstract Number: 988 • 2013 ACR/ARHP Annual Meeting
Lupus Education For Providers Serving The Asian American Community: Hospital For Special Surgery’s LANtern® (Lupus Asian Network) Initiative
Background/Purpose: Lupus affects Asian Americans 2-3 times more than their white counterparts, with studies demonstrating health disparities in severity and outcomes. Our hospital’s national support…Abstract Number: 989 • 2013 ACR/ARHP Annual Meeting
Reproductive Counseling Program For Lupus Patients At The Systemic Lupus Erythematosus-Antiphospholipid Syndrome Center Of Excellence At Hospital For Special Surgery
Background/Purpose: Maternal exposure to mycophenolate mofetil (MMF) during pregnancy is associated with increased risks of first trimester pregnancy loss and congenital malformations. Responding to this…Abstract Number: 951 • 2013 ACR/ARHP Annual Meeting
The Anti-IL-17A Monoclonal Antibody Secukinumab (AIN457) Inhibits Pro-Inflammatory Mediator Release From Human Primary Synoviocytes Costimulated With IL-17 and TNF
Background/Purpose: Fibroblast-like synoviocytes (FLS) are targets of the pro-inflammatory IL-17 cytokines and a major source of inflammatory mediators in the inflamed synovium in rheumatoid arthritis…Abstract Number: 968 • 2013 ACR/ARHP Annual Meeting
Success Of Educational Intervention In Improving The Management Of Rheumatoid Arthritis
Background/Purpose: In many patients with rheumatoid arthritis (RA), the disease is not adequately controlled and only a minority of patients attain the goal of consistent…Abstract Number: 969 • 2013 ACR/ARHP Annual Meeting
Increasing Rheumatology Exposure To Internal Medicine Residents: 3 Year Analysis Of A Web-Based Image Of The Month
Background/Purpose: A previous study has demonstrated a web based Image of the Month can increase rheumatology exposure for internal medicine residents over 1 year with…Abstract Number: 949 • 2013 ACR/ARHP Annual Meeting
Targeting CD1c-Expressing Mdcs To Inhibit Tcell Activation and Thymus and Activation Regulated Chemokine (TARC)-Dependent Chemotaxis In RA
Background/Purpose: Recently, we demonstrated strong Th1 and Th17 cytokine induction by CD1c+ myeloid dendritic cells (mDCs) from synovial fluid and identified thymic stromal lympopoeitin (TSLP)…Abstract Number: 950 • 2013 ACR/ARHP Annual Meeting
Changes In Circulating Visfatin Levels By Different Anti-Rheumatic Treatments: A Comparison Among Synthetic Disease Modifying Anti-Rheumatic Drugs, Tumor Necrosis Factor Blockade and B-Cell Depletion For Rheumatoid Arthritis
Background/Purpose: Visfatin is an insulin mimetic adipokine that has been originally described as a pre-B cell colony-enhancing factor. Association between elevated visfatin levels, disease activity…Abstract Number: 952 • 2013 ACR/ARHP Annual Meeting
CX3CR1 Deficiency Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation By Predominant Infiltration Of M2 Macrophages
Background/Purpose: CX3C chemokine receptor 1 (CX3CR1), a receptor for CX3CL1, has been identified as a key mediator of macrophage migration into injured tissue or inflammation…Abstract Number: 953 • 2013 ACR/ARHP Annual Meeting
Baseline Serum Interleukin-34 Levels Predict Radiographic Progression In Rheumatoid Arthritis Patients
Background/Purpose: Interleukin-34 (IL-34), a novel cytokine playing a critical role in osteoclastogenesis, recently was reported that its expression increases in the synovial tissue and sera…Abstract Number: 954 • 2013 ACR/ARHP Annual Meeting
Correlating The In Vivo Production Of IFNγ To Disease Parameters In TLR9-Induced Macrophage Activation Syndrome (MAS) In Mice
Background/Purpose: Cytokine release is the hallmark feature in mice given repeated injections of the TLR9 agonist, CpG-containing oligodeoxynucleotides (CpG-ODN), resulting in pathology resembling the human…Abstract Number: 955 • 2013 ACR/ARHP Annual Meeting
Myeloid Deletion Of SIRT1 Aggravates Serum Transfer Arthritis But Ameliorate Collagen-Induced Arthritis
Background/Purpose: SIRT1 plays a pivotal role in regulating the inflammatory response. Thus, we assessed the role of SIRT1 in K/BxN serum transfer arthritis as a…Abstract Number: 957 • 2013 ACR/ARHP Annual Meeting
The Role Of S100A4 As a Biological Marker Of Immune Response In Early Rheumatoid Arthritis
Background/Purpose: We have previously demonstrated that S100A4 is up-regulated in established rheumatoid arthritis (RA) and that S100A4 regulates apoptosis and synthesis of matrix degrading enzymes…Abstract Number: 958 • 2013 ACR/ARHP Annual Meeting
Serum Cytokine Changes In Rituximab-Treated Rheumatoid Arthritis Patients
Background/Purpose: Although rituximab therapy is successful in the majority of rheumatoid arthritis (RA) patients, 30-40% of patients do not respond. The mechanism behind this is…